Eisai
4523.T
#2008
Rank
โ‚น868.45 B
Marketcap
โ‚น3,081
Share price
-0.53%
Change (1 day)
15.70%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): โ‚น73.02

According to Eisai's latest financial reports the company's current EPS (TTM) is โ‚น80.28. In 2026 the company made an earnings per share (EPS) of โ‚น79.93 a decrease over its 2025 EPS that were of โ‚น101.23.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2026โ‚น79.93-21.04%
2025โ‚น101.2311.85%
2024โ‚น90.50-32.63%
2023โ‚น134.345.52%
2022โ‚น127.31-74.01%
2021โ‚น489.80-66.58%
2020โ‚น1,46598.24%
2019โ‚น739.1917.01%
2018โ‚น631.7237.78%
2017โ‚น458.52-27.62%
2016โ‚น633.5035.33%
2015โ‚น468.11-2.82%
2014โ‚น481.71-27.66%
2013โ‚น665.94-27.49%
2012โ‚น918.45-12.67%
2011โ‚น1,05288.08%
2010โ‚น559.20-11.06%
2009โ‚น628.76-390.15%
2008-โ‚น216.70-127.78%
2007โ‚น780.17347.11%
2006โ‚น174.494.38%
2005โ‚น167.187.4%
2004โ‚น155.6643.03%
2003โ‚น108.8425.09%
2002โ‚น87.0052.67%
2001โ‚น56.9969.76%
2000โ‚น33.57